Assessing Proto Labs (PRLB) Valuation After Strong 1 Year Share Price Rebound

What Proto Labs investors can glean from recent performance

Proto Labs (PRLB) has moved sharply over the past year, with the stock returning 57.3% and showing double digit gains over the past month and past 3 months, catching the attention of many investors.

Alongside that share price performance, the company reports annual revenue of US$533.1 million and net income of US$21.2 million, with recent annual revenue and net income growth rates of 6.4% and 24.4% respectively.

See our latest analysis for Proto Labs.

At a share price of US$63.25, Proto Labs has seen recent momentum cool slightly after a strong run, with a 30 day share price return of 17.7% and a 1 year total shareholder return of 57.3%. This suggests sentiment has improved over time even as short term pullbacks appear.

If this kind of rebound has you thinking about where else growth stories might be emerging, our screener of 22 top founder-led companies is a useful way to surface fresh ideas beyond your current watchlist.

So with Proto Labs trading at US$63.25 after a strong 1 year return, but still below the average analyst price target, should you see this as a genuine valuation gap or is the market already pricing in future growth?

Most Popular Narrative: 11.7% Undervalued

With Proto Labs last closing at $63.25 against a narrative fair value of $71.67, the current setup frames an interesting gap investors will want to understand.

Ongoing investments in sales enablement, marketing, and optimization of fulfillment channels are improving customer experience and wallet share, evidenced by higher revenue per customer (+11% y/y) and increased cross-platform adoption (+44% y/y), which points to future top-line growth and improved earnings quality.

Read the complete narrative.

Want to see what kind of revenue trajectory and margin lift could justify that higher fair value, and why the implied future P/E jumps meaningfully? The full narrative outlines the growth runway, the shift in profitability, and the earnings power the market would need to believe in for that pricing gap to make sense.

Result: Fair Value of $71.67 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are still pressure points to watch, especially customer concentration in Aerospace & Defense and ongoing margin strain if tariffs or weak European demand persist.

Find out about the key risks to this Proto Labs narrative.

Another View: High P/E Sends A Different Signal

While the narrative fair value of $71.67 suggests Proto Labs looks 11.7% undervalued, the current P/E of 70.8x tells a different story. It is more than double the US Machinery industry average of 29.9x and well above the fair ratio of 29.8x, which points to meaningful valuation risk if sentiment cools.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of optimism and valuation questions has you thinking harder about Proto Labs, now is a good time to study the numbers and form your own stance. You can start with its 2 key rewards.

Looking for more investment ideas?

If Proto Labs has sharpened your focus, now is the time to broaden your watchlist with other ideas that match the kind of edge you are looking for.

• Target potential mispricing with our list of 56 high quality undervalued stocks that may not yet be fully appreciated by the broader market.
• Prioritise resilience by scanning 80 resilient stocks with low risk scores that score well on stability, so short term swings are less likely to throw you off course.
• Hunt for future standouts using a screener containing 23 high quality undiscovered gems that most investors are not watching yet but already show solid fundamentals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com